JNJ-64619178, inhibitor of PRMT5, leads to the inhibition of symmetric arginine dimethylation of SMD1/3 proteins, core components of the spliceosome in the tumor and alters aberrant splicing by suppressing PRMT5 enzymatic activity [168,169]. This evidence concerns the gene PRMT5 and neoplasm.